Literature DB >> 1629825

Antibiotic allergy in systemic lupus erythematosus: a case-control study.

M Petri1, J Allbritton.   

Abstract

Antibiotic allergy, especially to sulfonamides, has been reported as both a predisposing factor and as an exacerbating agent in systemic lupus erythematosus (SLE). We surveyed 221 members of The Johns Hopkins Lupus Cohort and 2 control groups, consisting of 178 relatives and 186 best friends, for antibiotic allergy to penicillin/cephalosporins, sulfonamides, tetracyclines, and erythromycin. Antibiotic allergy was common in patients with SLE exposed to the drug: 27% penicillin/cephalosporin, 31% sulfonamide, 7% tetracycline, and 13% erythromycin. In all cases, the most common allergic reaction was rash. Worsening of SLE occurred in 21% of sulfonamide allergic reactions. Allergy to penicillin/cephalosporin (OR 2.3, 95% CI 1.5-3.6), sulfonamides (OR 2.4, 95% CI 1.2-4.7) and to erythromycin (OR 4.8, 95% CI 1.5-14.9) was significantly more common in exposed patients with SLE than in exposed controls. Thus, antibiotic allergy is a frequent finding in patients with SLE and, in the case of sulfonamide allergy, can be associated with lupus exacerbation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629825

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

Review 1.  Systemic lupus erythematosus: Diagnosis and clinical management.

Authors:  Andrea Fava; Michelle Petri
Journal:  J Autoimmun       Date:  2018-11-16       Impact factor: 7.094

Review 2.  Pneumocystis Pneumonia and the Rheumatologist: Which Patients Are At Risk and How Can PCP Be Prevented?

Authors:  Rachel M Wolfe; James E Peacock
Journal:  Curr Rheumatol Rep       Date:  2017-06       Impact factor: 4.592

3.  Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus.

Authors:  Linnette López-López; Noridza Rivera-Rodríguez; Luis M Vilá
Journal:  BMJ Case Rep       Date:  2012-09-12

Review 4.  Drug-induced glomerular disease: immune-mediated injury.

Authors:  Jonathan J Hogan; Glen S Markowitz; Jai Radhakrishnan
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-19       Impact factor: 8.237

Review 5.  Drug Allergy Delabeling Programs: Recent Strategies and Targeted Populations.

Authors:  Karen M Anstey; Lulu Tsao; Iris M Otani
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-15       Impact factor: 8.667

6.  Silicone breast implants and depression, fibromyalgia and chronic fatigue syndrome in a rheumatology clinic population.

Authors:  Thomas Khoo; Susanna Proudman; Vidya Limaye
Journal:  Clin Rheumatol       Date:  2019-01-31       Impact factor: 2.980

7.  Feasibility and validity were demonstrated of an online case-control study using the prototype of recent-onset systemic lupus erythematosus.

Authors:  Timothy McAlindon; Jun Wang; Margaret Formica; Ashley Kay; Hocine Tighiouart; Christine Chaisson; Jeremiah Fletcher
Journal:  J Clin Epidemiol       Date:  2008-03-14       Impact factor: 6.437

8.  IgE and non-IgE mediated allergic disorders in systemic lupus erythematosus.

Authors:  S Morton; B Palmer; K Muir; R J Powell
Journal:  Ann Rheum Dis       Date:  1998-11       Impact factor: 19.103

Review 9.  Pragmatic approaches to therapy for systemic lupus erythematosus.

Authors:  Wen Xiong; Robert G Lahita
Journal:  Nat Rev Rheumatol       Date:  2013-10-29       Impact factor: 20.543

10.  Low incidence of opportunistic Infections in Lupus Patients treated with Cyclophosphamide and Steroids in a Tertiary care setting.

Authors:  Shubhasree Banerjee; Ann Biehl; Maryam Ghaderi-Yeganeh; Zerai Manna; Sarfaraz Hasni
Journal:  Med Res Arch       Date:  2017-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.